$375 Million is the total value of Aviva Holdings Ltd.'s 10 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | MIRATI THERAPEUTICS INC | $147,704,000 | -4.5% | 3,135,966 | 0.0% | 39.41% | +57.0% | |
MDCO | MEDICINES CO | $113,022,000 | -18.5% | 3,778,742 | 0.0% | 30.15% | +33.9% | |
ESPR | ESPERION THERAPEUTICS INC NE | $53,248,000 | +13.2% | 1,200,100 | 0.0% | 14.21% | +86.0% | |
INSG | New | INSEEGO CORP | $34,829,000 | – | 9,046,500 | +100.0% | 9.29% | – |
MGNX | Sell | MACROGENICS INC. | $14,253,000 | -29.4% | 664,785 | -32.0% | 3.80% | +16.1% |
INSEEGO CORPnote 5.500% 6/1 | $11,222,000 | -95.6% | 13,700,000 | 0.0% | 2.99% | -92.8% | ||
SLDB | SOLID BIOSCIENCES INC. | $542,000 | +32.5% | 11,488 | 0.0% | 0.14% | +119.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Braslyn Ltd. #1
- Avid Ltd. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 100.0% |
INSEEGO CORP | 21 | Q3 2023 | 39.6% |
INSEEGO CORP | 14 | Q3 2023 | 10.2% |
PAMPA ENERGIA SA ADR | 12 | Q3 2022 | 26.0% |
MEDICINES CO | 11 | Q3 2019 | 87.4% |
ESPERION THERAPEUTICS INC NE | 9 | Q1 2019 | 14.2% |
TANGO THERAPEUTICS INC. | 9 | Q3 2023 | 0.2% |
SOLID BIOSCIENCES INC. | 9 | Q2 2020 | 0.1% |
INSEEGO CORP | 8 | Q1 2020 | 41.4% |
MACROGENICS INC. | 6 | Q4 2018 | 10.0% |
View Aviva Holdings Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Aviva Holdings Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.